Clinical Trial Update: Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating enzalutamide with leuprolide in nonmetastatic prostate cancer; results posted and study status is active not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone Sensitive Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Leuprolide (Leuprolide acetate)

Snippet

Sponsor: Pfizer | Conditions: Hormone Sensitive Prostate Cancer, Prostate Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-03-25